Citrus crops are among the world's most familiar fruits, but their genomes have remained difficult to interpret because of ...
Esophageal cancer, which is cancer of the swallowing tube, has only a 22.2% five-year relative survival rate, but early ...
A study recently published in Current Molecular Pharmacology has uncovered a novel mechanism by which the long non‑coding RNA ...
According to MarketsandMarkets™, the Epigenetics Market is projected to grow from about USD 2.22 billion in 2026 to USD 3.92 ...
The “dark proteome” includes uncharacterized proteins that may influence cancer growth, immune evasion, and therapy ...
Katelyn is a reporter with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...
Resalis Therapeutics today announced the dosing of the first participant in a Phase 1b clinical study of its lead candidate, RES-010, a novel antisense oligonucleotide targeting microRNA-22 (miR-22), ...
In cancer research, one person's junk is increasingly becoming another person's treasure. Scientists have now uncovered new evidence showing how recently evolved "junk DNA" genetic elements can become ...
Join us for a fascinating conversation with Dr. Zehra Nizami, Principal Scientist, Head of Business Development & ...
Biolevate, an AI-native knowledge platform company for life sciences, today announced it is building with the NVIDIA BioNeMo Agent Toolkit to support the next phase of its agentic discovery roadmap.
Neurological disorders represent a growing global health challenge, yet the molecular mechanisms underlying their onset and progression remain incompletely ...
According to MarketsandMarkets, the Epigenetics Market is projected to grow from about USD 2.22 billion in 2026 to USD 3.92 billion by 2031 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results